Globe Life Inc (GL)
Official siteFINANCIAL SERVICES • INSURANCE - LIFE • NYSE
Market Cap: $12.13B
Last updated: Nov 17, 2026 at 11:06 AM ET
Globe Life Inc (GL) Earnings: Report Dates and Results
Globe Life (GL) is expected to report earnings on Feb 2, 2027. In the quarter ended Sep 30, 2026, Globe Life reported EPS of $4.84, below the $4.87 estimate. It beat the EPS estimate in 3 of the last 8 quarters.
Earnings
Performance (10Y)
Upcoming Estimates
Next Report
GL has an expected report date of Feb 2, 2027. Analysts' consensus for the quarter ending Dec 31, 2026 is 10.0% above the $3.39 reported for the quarter ended Dec 31, 2025.
GL Earnings Call
The latest GL earnings call transcript on file is labeled 2026Q3.
Read the 2026Q3 transcriptEarnings History
Of the 40 quarters below that had an estimate, GL beat 27, missed 11 and matched 2. Revenue for the quarter ended Sep 30, 2026 was $1.60B, up 6.0% from $1.51B a year earlier.
| Quarter ended | EPS | Estimate | Range | Surprise | Result | YoY | Analysts | Revisions | Reported | Revenue |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 30, 2026 | $4.84 | $4.87 | $4.77 - $4.99 | -0.62% | Miss | +0.6% | 10 | 0 up, 2 down | Oct 21, 2026 | $1.60B |
| Jun 30, 2026 | $3.61 | $3.67 | $3.62 - $3.75 | -1.63% | Miss | +10.4% | 10 | 2 up, 0 down | Jul 22, 2026 | $1.60B |
| Mar 31, 2026 | $3.43 | $3.48 | $3.40 - $3.63 | -1.44% | Miss | +11.7% | 10 | 1 up, 3 down | Apr 22, 2026 | $1.56B |
| Dec 31, 2025 | $3.39 | $3.44 | $3.35 - $3.52 | -1.45% | Miss | +8.0% | 9 | 1 up, 0 down | Feb 4, 2026 | $1.52B |
| Sep 30, 2025 | $4.81 | $4.54 | $4.00 - $4.76 | +5.95% | Beat | +37.8% | 11 | 2 up, 1 down | Oct 22, 2025 | $1.51B |
| Jun 30, 2025 | $3.27 | $3.25 | $3.22 - $3.37 | +0.62% | Beat | +10.1% | 9 | 0 up, 9 down | Jul 23, 2025 | $1.48B |
| Mar 31, 2025 | $3.07 | $3.24 | $3.20 - $3.29 | -5.25% | Miss | +10.4% | 11 | 1 up, 3 down | Apr 30, 2025 | $1.48B |
| Dec 31, 2024 | $3.14 | $3.12 | $3.03 - $3.19 | +0.64% | Beat | +12.1% | 10 | 1 up, 1 down | Feb 5, 2025 | $1.47B |
| Sep 30, 2024 | $3.49 | $3.06 | $3.03 - $3.11 | +14.05% | Beat | +28.8% | 10 | 4 up, 0 down | Oct 23, 2024 | $1.46B |
| Jun 30, 2024 | $2.97 | $2.91 | $2.86 - $2.95 | +2.06% | Beat | +13.8% | 8 | 1 up, 0 down | Jul 24, 2024 | $1.44B |
| Mar 31, 2024 | $2.78 | $2.79 | $2.75 - $2.82 | -0.36% | Miss | +9.9% | 9 | 2 up, 0 down | Apr 22, 2024 | $1.42B |
| Dec 31, 2023 | $2.80 | $2.73 | $2.70 - $2.75 | +2.56% | Beat | +25.0% | 9 | 1 up, 0 down | Feb 7, 2024 | $1.42B |
| Sep 30, 2023 | $2.71 | $2.65 | $2.61 - $2.67 | +2.26% | Beat | +26.0% | 8 | 2 up, 0 down | Oct 25, 2023 | $1.38B |
| Jun 30, 2023 | $2.61 | $2.58 | $2.53 - $2.61 | +1.16% | Beat | +26.1% | 8 | 3 up, 0 down | Jul 26, 2023 | $1.33B |
| Mar 31, 2023 | $2.53 | $2.47 | $2.39 - $2.54 | +2.43% | Beat | +48.8% | 10 | 1 up, 0 down | May 3, 2023 | $1.32B |
| Dec 31, 2022 | $2.24 | $2.17 | $2.14 - $2.24 | +3.23% | Beat | +31.8% | 9 | 0 up, 0 down | Feb 1, 2023 | $2.41B |
| Sep 30, 2022 | $2.15 | $2.10 | $2.01 - $2.15 | +2.38% | Beat | +20.8% | 9 | 2 up, 2 down | Oct 26, 2022 | $217.96M |
| Jun 30, 2022 | $2.07 | $2.05 | $2.01 - $2.12 | +0.98% | Beat | +11.9% | 8 | 3 up, 1 down | Jul 27, 2022 | $1.29B |
| Mar 31, 2022 | $1.70 | $1.73 | $1.48 - $1.94 | -1.73% | Miss | +11.1% | 9 | 1 up, 1 down | Apr 20, 2022 | $1.30B |
| Dec 31, 2021 | $1.70 | $1.76 | $1.68 - $1.84 | -3.41% | Miss | -2.3% | 9 | N/A | Feb 2, 2022 | $1.30B |
| Sep 30, 2021 | $1.78 | $1.89 | $1.79 - $1.99 | -5.82% | Miss | +1.7% | 7 | N/A | Oct 20, 2021 | $1.28B |
| Jun 30, 2021 | $1.85 | $1.82 | $1.78 - $1.86 | +1.65% | Beat | +12.1% | 7 | N/A | Jul 21, 2021 | $1.27B |
| Mar 31, 2021 | $1.53 | $1.61 | $1.50 - $1.76 | -4.97% | Miss | -11.6% | 7 | N/A | Apr 21, 2021 | $1.27B |
| Dec 31, 2020 | $1.74 | $1.71 | $1.59 - $1.80 | +1.75% | Beat | +2.4% | 7 | N/A | Feb 2, 2021 | $3.14B |
| Sep 30, 2020 | $1.75 | $1.75 | $1.65 - $1.90 | 0.00% | In line | +1.2% | 7 | N/A | Oct 21, 2020 | $233.22M |
| Jun 30, 2020 | $1.65 | $1.51 | $1.32 - $1.76 | +9.27% | Beat | -1.2% | 9 | N/A | Jul 22, 2020 | $227.18M |
| Mar 31, 2020 | $1.73 | $1.71 | $1.69 - $1.75 | +1.17% | Beat | +5.5% | 7 | N/A | Apr 22, 2020 | $1.13B |
| Dec 31, 2019 | $1.70 | $1.72 | $1.70 - $1.75 | -1.16% | Miss | +9.0% | 8 | N/A | Feb 4, 2020 | $2.03B |
| Sep 30, 2019 | $1.73 | $1.69 | $1.67 - $1.72 | +2.37% | Beat | +8.8% | 10 | N/A | Oct 23, 2019 | $1.14B |
| Jun 30, 2019 | $1.67 | $1.65 | N/A | +1.21% | Beat | +10.6% | N/A | N/A | Jul 24, 2019 | $1.13B |
| Mar 31, 2019 | $1.64 | $1.58 | N/A | +3.80% | Beat | +11.6% | N/A | N/A | Apr 17, 2019 | $226.91M |
| Dec 31, 2018 | $1.56 | $1.56 | N/A | 0.00% | In line | +25.8% | N/A | N/A | Feb 5, 2019 | $1.07B |
| Sep 30, 2018 | $1.59 | $1.53 | N/A | +3.92% | Beat | +29.3% | N/A | N/A | Oct 24, 2018 | $1.08B |
| Jun 30, 2018 | $1.51 | $1.49 | N/A | +1.34% | Beat | +26.9% | N/A | N/A | Jul 25, 2018 | $1.08B |
| Mar 31, 2018 | $1.47 | $1.45 | N/A | +1.38% | Beat | +27.8% | N/A | N/A | Apr 18, 2018 | $1.07B |
| Dec 31, 2017 | $1.24 | $1.23 | N/A | +0.81% | Beat | +7.8% | N/A | N/A | Feb 7, 2018 | N/A |
| Sep 30, 2017 | $1.23 | $1.20 | N/A | +2.50% | Beat | +7.0% | N/A | N/A | Oct 24, 2017 | $1.05B |
| Jun 30, 2017 | $1.19 | $1.17 | N/A | +1.71% | Beat | +7.2% | N/A | N/A | Jul 26, 2017 | $1.03B |
| Mar 31, 2017 | $1.15 | $1.14 | N/A | +0.88% | Beat | +6.5% | N/A | N/A | Apr 19, 2017 | $1.02B |
| Dec 31, 2016 | $1.15 | $1.13 | N/A | +1.77% | Beat | +9.5% | N/A | N/A | Feb 1, 2017 | $428.92M |
Annual EPS
EPS for the fiscal year ended Dec 31, 2025 was $14.54, up 17.4% from the year before. It was $4.49 for the year ended Dec 31, 2016, the oldest of the 10 fiscal years shown.
| Fiscal year ended | EPS | Change |
|---|---|---|
| Dec 31, 2025 | $14.54 | +17.4% |
| Dec 31, 2024 | $12.38 | +16.2% |
| Dec 31, 2023 | $10.65 | +30.5% |
| Dec 31, 2022 | $8.16 | +19.0% |
| Dec 31, 2021 | $6.86 | N/A |
| Dec 31, 2020 | $6.87 | +1.9% |
| Dec 31, 2019 | $6.74 | +10.0% |
| Dec 31, 2018 | $6.13 | +27.4% |
| Dec 31, 2017 | $4.81 | +7.1% |
| Dec 31, 2016 | $4.49 | N/A |
Earnings Calls
The 8 most recent earnings calls are listed below; the latest, 2026Q3 for the period ended Sep 30, 2026, runs about 11,000 words across 16 speakers.
| Call | Period ending | Words | Speakers | Transcript |
|---|---|---|---|---|
| 2026Q3 | Sep 30, 2026 | 10,586 | 16 | |
| 2026Q2 | Jun 30, 2026 | 8,343 | 15 | |
| 2026Q1 | Mar 31, 2026 | 7,989 | 15 | |
| 2025Q4 | Dec 31, 2025 | 7,688 | 12 | |
| 2025Q3 | Sep 30, 2025 | 7,313 | 15 | |
| 2025Q2 | Jun 30, 2025 | 8,710 | 16 | |
| 2025Q1 | Mar 31, 2025 | 8,357 | 16 | |
| 2024Q4 | Dec 31, 2024 | 8,903 | 14 |
2026Q3 Earnings Call
Opening remarks
Stephen Mota Vice President of Investor Relations Thank you. Good morning, everyone. Joining the call today are Frank Martin Svoboda and Matt Darden, our co-chief executive officers; Thomas Peter Kalmbach, our chief financial officer; Mike Majors, our chief strategy officer; and Brian Mitchell, our general counsel. Some of our comments or answers to your questions may contain forward-looking statements that are provided for general guidance purposes only. Accordingly, please refer to our earnings release, 10-Ks, and any subsequent Forms 10-Q on file with the SEC. Some of our comments may also contain non-GAAP measures. Please see our earnings release and website for a discussion of these terms and reconciliations to GAAP measures. I will now turn the call over to Frank.
Frank Martin Svoboda Co-CEO Thank you, Stephen, and good morning, everyone. In the third quarter, net income was $361 million, or $4.62 per share, a decrease of 2% from $4.73 per share a year ago. Net operating income for the quarter was $379 million, or $4.84 per share, an increase of 1% from $4.81 per share a year ago. As a reminder, both net income and net operating income are impacted in the third quarter of each year by the annual updating of our assumptions utilized in establishing our policy obligations. As was the case in 2025, we recorded a remeasurement gain related to assumption updates this quarter, reflecting our positive outlook for future policy obligations as our actual claims experience continues to be favorable compared to those long-term assumptions. In addition, underwriting results this quarter at United American General Agency Division were adversely impacted by a process change at CMS, the government agency that administers Medicare Supplement claims, and high-severity claims at Evri, the developing group health business that is included in United American's results. Matt and Tom will talk more about these items in their comments. On a GAAP-reported basis, return on equity through September 30 is 19.7%, and book value per share is $85.35, up 23% from a year ago. Excluding accumulated other comprehensive income, or AOCI, return on equity is 15.9%, and book value per share as of September 30 is $103.62, up 11% from a year ago. Now, in our insurance operations, total premium revenue in the third quarter grew 7% from the year-ago quarter. For the full year, we expect total premium revenue growth to be around 6.5%. Life premium revenue for the third quarter increased 2% from the year-ago quarter to $865 million. For the full year, we expect life premium revenue to grow between 2.5% and 2.75%, driven by strong premium growth in our American Income and Liberty National divisions.
Frequently Asked Questions About GL
When is Globe Life's next earnings date?
Globe Life's next earnings report is expected for Feb 2, 2027.
Did GL beat earnings estimates last quarter?
No. Globe Life reported EPS of $4.84 for the quarter ended Sep 30, 2026, below the $4.87 estimate by 0.62%.
What EPS do analysts expect from GL next quarter?
The consensus EPS estimate for Globe Life for the quarter ending Dec 31, 2026 is $3.73 from 17 analysts, with estimates from $3.47 to $3.86.
How often does GL beat earnings estimates?
Globe Life beat the EPS estimate in 3 of the last 8 quarters, with an average surprise of -0.40%.
GL pages: Overview, Dividends, Earnings, Forecast, Financials, Valuation, Competitors